CPC Scientific Inc. and UNC Lineberger Comprehensive Cancer Center Announce Neoantigen Peptide Collaboration
[..] to Manufacture Neoantigen Peptides for the PANDA (Personalized and Adaptive) Cancer Vaccine Program.
Vaccines that activate the immune system play a key role in the prevention and treatment of human diseases. The development of cancer vaccines, however, have only been effective in virus-caused cancers such as human papillomavirus-
Peptide neoantigen therapy constitutes a significant paradigm-shift in GMP peptide manufacturing due to the need for multiple unique peptide sequences targets and rapid synthesis, quality control, and release. With these changes in mind, CPC Scientific has launched our new PeptiVac neoantigen manufacturing platform:
About CPC Scientific CPC Scientific is a globally recognized and leading CDMO specializing in synthetic peptide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. We boast the largest GMP peptide facility in the world, which successfully has undergone multiple FDA inspections and audits by global pharma organizations. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing.
About UNC Lineberger Comprehensive Cancer Center The UNC Lineberger comprehensive Cancer Center, founded in 1975, is one of 40 National Cancer Institute (NCl)-designated comprehensive cancer centers in the country. The Center's mission is to reduce cancer occurrence and death in North Carolina and the nation through research, treatment, training and outreach.
Director of Marketing